Section Arrow
Quote
INSP.NYSE
- Inspire Medical Systems
Quotes are at least 15-min delayed:2025/06/28 11:16 EDT
Last
 132.41
+2.7 (+2.08%)
Day High 
132.76 
Prev. Close
129.71 
1-M High
147.66 
Volume 
526.76K 
Bid
131.47
Ask
132.73
Day Low
128.45 
Open
129.01 
1-M Low
125.22 
Market Cap 
3.83B 
Currency USD 
P/E 59.23 
%Yield -- 
10-SMA 129.76 
20-SMA 133.1 
50-SMA 144.65 
52-W High 225 
52-W Low 123 
Exchange NYSE 
Valuation Estimation
EPS (Current/Estimated)
2.19/3.32
Enterprise Value
3.86B
Balance Sheet
Book Value Per Share
21.56
Cash Flow
Cash Flow Yield
0.03
Income Statement
Total Revenue
802.80M
Operating Revenue Per Share
19.33
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
AMIXAutonomix Medical Inc2.01+0.76+60.80%-- 
NAOVNanoVibronix Inc1.17+0.3009+34.62%-- 
BFLYButterfly Network1.96-0.06-2.97%-- 
BBLGBone Biologics Corp4.58+0.42+10.10%0.08PE
BSXBoston Scientific Corp106.53+1.95+1.86%76.05PE
Quotes are at least 15-min delayed：2025/06/28 11:16 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.